小智港股覆盤 | 11月9日
今日,港股三大指數集體上漲。截止收盤,恆生指數漲0.2%,報24813點。國企指數漲0.14%,報8806點。恆生科技指數漲0.45%,報6221點。市場約882只個股上漲,804只個股下跌。成交額突破985.74億港幣,和昨天同期相比下跌19.16%。南下資金淨流出5.4億港幣。

盤面上,CRO板塊全線走強。藥明生物漲超10%;康龍化成漲超8%;昭衍新藥漲超7%;泰格醫藥漲超5%;藥明康德漲超4%。萬科企業獲大行一致看好,瑞信予藥明生物目標價151港元;Aggregate of abrdn plc增持泰格醫藥40.13萬股,每股作價約139.80港元;Wellington Management Group LLP增持藥明康德約34.52萬股,每股作價約160.63港元。

醫療設備板塊暴漲。微創機器人-B漲超20%;官醞控股漲超7%;心通醫療-B漲超5%;愛康醫療、先瑞達醫療-B等多股漲超4%。微創機器人首掛收報45.8元,較招股價高6.02%;心通醫療向4C Medical追加不逾2,500萬美元投資。

航天國防板塊漲幅較前。中航科工漲超4%。

個人用品板塊走弱。自然美跌超8%;霸王集團、中證國際等多股跌超4%;中國金典集團、恆安國際等多股跌超2%。

食品零售板塊走弱。展程控股跌超7%;領智金融跌超3%;香港食品投資、大洋環球控股、聯華超市等多股跌超2%。領智金融料2021年第三季度淨虧損收窄至約2000萬港元。

uSMART智能寫手的信息、數據均來自媒體公開報道,智能寫手不能保證其完全準確,內容僅供參考,不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.